The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Intrinsic Therapeutics sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Intrinsic Therapeutics Inc, United States Revenue

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

Intrinsic Therapeutics Inc (Intrinsic) is a medical device company that develops medical devices for the treatment of lumbar disc herniations. The company offers prosthesis for partial anulus replacement following discectomy surgery, prosthesis for partial anulus replacement, and anular closure device that is designed for patients with lumbar disc herniation and large anular defects. Its prosthesis is used in reduction of repeat surgeries required for post-discectomy patients. Intrinsic also offers medical education support programs for health care professionals to optimize clinical outcomes. The company markets its products in Germany, Austria, Chile, Australia, Colombia, the Czech Republic, Costa Rica, Italy, Israel, Mexico, Poland and others. Intrinsic is headquartered in Woburn, Massachusetts, the US.

The key metrics of Intrinsic Therapeutics related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Intrinsic Therapeutics is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Intrinsic Therapeutics.

For a detailed understanding of the performance of Intrinsic Therapeutics, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.